Cargando…
Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
Advancing age and disease duration both contribute to cortical thinning in Parkinson’s disease (PD), but the pathological interactions between them are poorly described. This study aims to distinguish patterns of cortical decline determined by advancing age and disease duration in PD. A convenience...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898918/ https://www.ncbi.nlm.nih.gov/pubmed/27330836 http://dx.doi.org/10.14336/AD.2015.1110 |
_version_ | 1782436414349115392 |
---|---|
author | Claassen, Daniel O. Dobolyi, David G. Isaacs, David A. Roman, Olivia C. Herb, Joshua Wylie, Scott A. Neimat, Joseph S. Donahue, Manus J. Hedera, Peter Zald, David H. Landman, Bennett A. Bowman, Aaron B. Dawant, Benoit M. Rane, Swati |
author_facet | Claassen, Daniel O. Dobolyi, David G. Isaacs, David A. Roman, Olivia C. Herb, Joshua Wylie, Scott A. Neimat, Joseph S. Donahue, Manus J. Hedera, Peter Zald, David H. Landman, Bennett A. Bowman, Aaron B. Dawant, Benoit M. Rane, Swati |
author_sort | Claassen, Daniel O. |
collection | PubMed |
description | Advancing age and disease duration both contribute to cortical thinning in Parkinson’s disease (PD), but the pathological interactions between them are poorly described. This study aims to distinguish patterns of cortical decline determined by advancing age and disease duration in PD. A convenience cohort of 177 consecutive PD patients, identified at the Vanderbilt University Movement Disorders Clinic as part of a clinical evaluation for Deep Brain Stimulation (age: M= 62.0, SD 9.3), completed a standardized clinical assessment, along with structural brain Magnetic Resonance Imaging scan. Age and gender matched controls (n=53) were obtained from the Alzheimer Disease Neuroimaging Initiative and Progressive Parkinson’s Marker Initiative (age: M= 63.4, SD 12.2). Estimated changes in cortical thickness were modeled with advancing age, disease duration, and their interaction. The best-fitting model, linear or curvilinear (2(nd), or 3(rd) order natural spline), was defined using the minimum Akaike Information Criterion, and illustrated on a 3-dimensional brain. Three curvilinear patterns of cortical thinning were identified: early decline, late decline, and early-stable-late. In contrast to healthy controls, the best-fit model for age related changes in PD is curvilinear (early decline), particularly in frontal and precuneus regions. With advancing disease duration, a curvilinear model depicts accelerating decline in the occipital cortex. A significant interaction between advancing age and disease duration is evident in frontal, motor, and posterior parietal areas. Study results support the hypothesis that advancing age and disease duration differentially affect regional cortical thickness and display regional dependent linear and curvilinear patterns of thinning. |
format | Online Article Text |
id | pubmed-4898918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | JKL International LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-48989182016-06-21 Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease Claassen, Daniel O. Dobolyi, David G. Isaacs, David A. Roman, Olivia C. Herb, Joshua Wylie, Scott A. Neimat, Joseph S. Donahue, Manus J. Hedera, Peter Zald, David H. Landman, Bennett A. Bowman, Aaron B. Dawant, Benoit M. Rane, Swati Aging Dis Original Article Advancing age and disease duration both contribute to cortical thinning in Parkinson’s disease (PD), but the pathological interactions between them are poorly described. This study aims to distinguish patterns of cortical decline determined by advancing age and disease duration in PD. A convenience cohort of 177 consecutive PD patients, identified at the Vanderbilt University Movement Disorders Clinic as part of a clinical evaluation for Deep Brain Stimulation (age: M= 62.0, SD 9.3), completed a standardized clinical assessment, along with structural brain Magnetic Resonance Imaging scan. Age and gender matched controls (n=53) were obtained from the Alzheimer Disease Neuroimaging Initiative and Progressive Parkinson’s Marker Initiative (age: M= 63.4, SD 12.2). Estimated changes in cortical thickness were modeled with advancing age, disease duration, and their interaction. The best-fitting model, linear or curvilinear (2(nd), or 3(rd) order natural spline), was defined using the minimum Akaike Information Criterion, and illustrated on a 3-dimensional brain. Three curvilinear patterns of cortical thinning were identified: early decline, late decline, and early-stable-late. In contrast to healthy controls, the best-fit model for age related changes in PD is curvilinear (early decline), particularly in frontal and precuneus regions. With advancing disease duration, a curvilinear model depicts accelerating decline in the occipital cortex. A significant interaction between advancing age and disease duration is evident in frontal, motor, and posterior parietal areas. Study results support the hypothesis that advancing age and disease duration differentially affect regional cortical thickness and display regional dependent linear and curvilinear patterns of thinning. JKL International LLC 2016-05-27 /pmc/articles/PMC4898918/ /pubmed/27330836 http://dx.doi.org/10.14336/AD.2015.1110 Text en Copyright: © 2016 Claassen DO, et al. http://creativecommons.org/licenses/by/2.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Original Article Claassen, Daniel O. Dobolyi, David G. Isaacs, David A. Roman, Olivia C. Herb, Joshua Wylie, Scott A. Neimat, Joseph S. Donahue, Manus J. Hedera, Peter Zald, David H. Landman, Bennett A. Bowman, Aaron B. Dawant, Benoit M. Rane, Swati Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease |
title | Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease |
title_full | Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease |
title_fullStr | Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease |
title_full_unstemmed | Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease |
title_short | Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease |
title_sort | linear and curvilinear trajectories of cortical loss with advancing age and disease duration in parkinson’s disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898918/ https://www.ncbi.nlm.nih.gov/pubmed/27330836 http://dx.doi.org/10.14336/AD.2015.1110 |
work_keys_str_mv | AT claassendanielo linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT dobolyidavidg linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT isaacsdavida linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT romanoliviac linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT herbjoshua linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT wyliescotta linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT neimatjosephs linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT donahuemanusj linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT hederapeter linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT zalddavidh linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT landmanbennetta linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT bowmanaaronb linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT dawantbenoitm linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease AT raneswati linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease |